|Grant Affiliation:||Barouch: Therapeutic Efficacy of Potent Broadly Neutralizing mAbs for HIV-1 Eradication|
|Strategy:||Prophylactic neutralizing Ab|
|Study Type:||Antibody Screening|
|Study Start Date:||2016-03-15|
|Study Made Public:||NA|
To compare the spectrum of neutralizing activity by three candidate clinical clones of PGDM1400
CAVD 554 is an immunogenicity study to characterize new PGDM1400 clone antibodies.
Sign in to see full information about this study and to download study data.
ProductsNo Products used in study
No non-integrated data is available for this study.